OCON Therapeutics takes the lead in uterine health advocacy with NIH and Bill and Melinda Gates Foundation

OCON Therapeutics, a pioneering women’s health company, is taking the lead in advocating for uterine health, as two key members of its management team, Keren Leshem and Daniela Schardinger, join the esteemed Innovation Equity Forum (IEF) Steering Committee of the NIH and Bill and Melinda Gates Foundation.

This new collaboration aims to propose and elevate the focus on unmet needs by taking a holistic approach to women’s health, and address the lack of progress in this critical area, transcending the traditional emphasis mainly on fertility and childbirth.

A global commitment to uterine health

The leadership of OCON Therapeutics, NIH and the Bill and Melinda Gates Foundation amongst other leaders and founders in this space, underscores their shared commitment to improving women’s health and its research and offerings on a global scale.

While the foundation has been instrumental in addressing various health challenges, including reproductive health, maternal care, and family planning in low- and middle-income countries (LMICs), the participation with OCON Therapeutics expands the focus to encompass the unmet needs of women worldwide related to uterine disorders, including uterine bleeding, uterine fibroids and endometriosis.

Holistic approach to uterine disorders

Uterine disorders, such as uterine bleeding, uterine fibroids, and endometriosis, affect millions of women globally and have a profound impact on their quality of life.

OCON Therapeutics recognises the urgency to address these conditions comprehensively, considering the physical, emotional, and social implications they impose.

By advocating a holistic approach, the company aims to promote greater understanding, awareness, and innovation in the diagnosis, treatment, and management of uterine disorders.

Empowering women beyond fertility and childbirth

The inclusion of uterine disorders in the Innovation Equity Forum Steering Committee’s agenda signifies a significant shift in how women’s health is perceived and prioritised.

While fertility and childbirth have traditionally been the main focus, this collaboration acknowledges that women are more than just their reproductive capabilities.

By addressing the unmet needs of uterine health, the aim is to empower women with comprehensive care and support throughout their lives.

Driving innovation for uterine health

One of the critical objectives of this collaboration is to stimulate innovation in the field of uterine health. OCON Therapeutics, with its expertise in women’s health solutions, brings valuable insights and cutting-edge technologies to the table.

By leveraging the foundation’s resources and global reach, the company aims to propel research, development, and commercialisation efforts in the area of uterine disorders.

This collaborative endeavor has the potential to pave the way for groundbreaking advancements, improved treatment options, and enhanced quality of life for women around the world.

Raising awareness and advocacy

To effect real change, raising awareness and advocating for the unmet needs of uterine health are vital. OCON Therapeutics’ team works diligently to amplify the conversation surrounding uterine disorders.

Through educational initiatives, and strategic partnerships, the aim is to drive public discourse, influence policies, and secure support from key stakeholders, ultimately catalysing positive change and promoting equity in women’s healthcare.

By joining the Innovation Equity Forum Steering Committee, OCON Therapeutics’ management members will play a pivotal role in raising awareness and making uterine health a key focus of the foundation.

This collaboration aims to tackle the unmet needs related to uterine disorders globally, transcending geographical boundaries and emphasising the holistic wellbeing of women.

Through innovation, advocacy, and a commitment to comprehensive care, OCON Therapeutics, NIH and the Bill and Melinda Gates Foundation are set to make a lasting impact in the field of women’s health and bring about positive change for women worldwide.